Panacea Acquisition Stock Quote NUVB - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

3.79

Bid

Ask

Volume

1,238,668

3.64 Day's Range 3.83

0.95 52 Week Range 4.1598

Market Cap

936.777M

Previous Close

3.69

Open

3.75

Last Trade

3.83

Last Trade Time

Financial Volume

$ 4,606,636

VWAP

3.719

Average Volume (3m)

1,643,447

Shares Outstanding

247,170,648

Dividend Yield

PE Ratio

-12.16

Earnings Per Share (EPS)

-0.31

Revenue

Net Profit

-75.8M

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

ecor1cap.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Panacea Acquisition Corp is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker NUVB. The last closing price for Panacea Acquisition was $3.69. Over the last year, Panacea Acquisition shares have traded in a share price range of $ 0.95 to $ 4.1598.

Panacea Acquisition currently has 247,170,648 shares outstanding. The market capitalization of Panacea Acquisition is $912.06 million. Panacea Acquisition has a price to earnings ratio (PE ratio) of -12.16.

Nuvation Bio Announces Updates and Upcoming Presentations for its ROS1 Inhibitor, Taletrectinib

Company to present pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies at the European Society of Medical Oncology (ESMO) Congress 2024, which will support Nuvation Bio’s New Drug...

Form PRER14A - Preliminary Proxy Soliciting materials

Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting

Tumors shrank in 91% of taletrectinib-treated patients with advanced ROS1-positive NSCLC who were ROS1 TKI-naïve and 52% of those who were ROS1 TKI-pretreated in the study Responses were durable...

Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Nuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.62	19.5583596215	3.17	3.83	2.985	1535369	3.35244975	CS
4	0.71	23.0519480519	3.08	3.83	2.87	2070810	3.16856853	CS
12	0.41	12.1301775148	3.38	3.83	2.57	1643447	3.10562948	CS
26	2.08	121.637426901	1.71	4.1598	1.52	1473116	2.95828226	CS
52	1.97	108.241758242	1.82	4.1598	0.95	1244988	2.28069069	CS
156	-4.8	-55.8789289872	8.59	10.45	0.95	940873	3.63419217	CS
260	-6.21	-62.1	10	15.23	0.95	935708	4.62841325	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M